CFM
AVNS

Catalyst Funds Management’s Avanos Medical AVNS Stock Holding History

Catalyst Funds Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,200
Closed -$28.8K – 401
2024
Q3 		$28.8K Hold
1,200
– – 0.01% 995
2024
Q2 		$23.9K Buy
1,200
+1,100
+1,100% +$21.4K 0.01% 626
2024
Q1 		$1.99K Buy
+100
New +$1.93K ﹤0.01% 1055

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Catalyst Funds Management's AVNS Position: Q4 2024 in Review

Catalyst Funds Management sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 1,200 shares — an estimated $28.8K sold.

Catalyst Funds Management first reported a position in AVNS in Q1 2024 and held it in 3 quarters. The position peaked at $28.8K in Q3 2024. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Catalyst Funds Management reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 1,200 Avanos Medical shares in Q4 2024, an estimated $28.8K.
  • Catalyst Funds Management first reported a position in Avanos Medical in Q1 2024 and held it in 3 quarters.
  • Catalyst Funds Management's Avanos Medical position peaked at $28.8K in Q3 2024.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.